[Use of intravenous immunoglobulin in treatment of neoplasms and hematologic disorders in children].A risk factor analysis of outcomes after unrelated cord blood transplantation for children with Wiskott-Aldrich syndromec.1810C>T polymorphism of NTRK1 gene is associated with reduced survival in neuroblastoma patients.Baicalin from the extract of Scutellaria baicalensis affects the innate immunity and apoptosis in leukocytes of children with acute lymphocytic leukemia.A randomized comparison of two prophylaxis regimens and a paired comparison of on-demand and prophylaxis treatments in hemophilia A managementDevelopment of treatment and clinical results in childhood acute myeloid leukemia in Poland.Unrelated alternative donor transplantation for severe acquired aplastic anemia: a study from the French Society of Bone Marrow Transplantation and Cell Therapies and the EBMT Severe Aplastic Anemia Working Party.Quality of life and ethical and legal dilemmas in children during and after hematopoietic SCT procedure.The influence of genetic RFC1, MS and MTHFR polymorphisms on the risk of acute lymphoblastic leukemia relapse in children and the adverse effects of methotrexate.Management of familial hypercholesterolemia in children and adolescents. Position paper of the Polish Lipid Expert Forum.[Long-term observations of children with acute lymphoblastic leukemia and high leukocytosis treated according to modified "New York" protocols (1987-2003)].Steroid-sparing effect of extracorporeal photopheresis in the therapy of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.[The efficacy of BFM-90 program in the treatment of acute lymphoblastic leukemia in children in the studies of Polish pediatric leukemia/lymphoma group].[The health state evaluation in persons after therapy of Hodgkin's disease in childhood: report of the Polish Pediatric Leukemia/Lymphoma Study Group].In vitro activity of oxazaphosphorines in childhood acute leukemia: preliminary report.Cross-resistance to five glucocorticoids in childhood acute lymphoblastic and non-lymphoblastic leukemia samples tested by the MTT assay: preliminary report.The influence of intracellular idarubicin and daunorubicin levels on drug cytotoxicity in childhood acute leukemia.Adoptive therapy with donor lymphocyte infusion after allogenic hematopoietic SCT in pediatric patients.The BCL-2 protein in precursor B acute lymphoblastic leukemia in children.Incidence and clinical characteristics of second malignant neoplasms in children: a multicenter study of a polish pediatric leukemia/lymphoma group.[Efficacy of idarubicin in the treatment of childhood acute non-lymphoblastic leukemia: report of Polish Pediatric Leukemia/Lymphoma Study Group].[What to improve in approach to diagnose and treat pediatric myelodysplastic syndromes and juvenile myelomonocytic leukemia in Poland?].[Influence of age on treatment results in children and adolescents with Hodgkin's disease].[Treatment results in children with standard-risk acute lymphoblastic leukemia. Report of the Polish Pediatric Leukemia/Lymphoma Study Group].[Autologous stem-cell transplantations in children with non-Hodgkin lymphomas].[Over 30-year experience of Polish Pediatric Leukemia/Lymphoma Study Group for treatment of Hodgkin's disease in children and adolescents: improvement curability and decrease of serious complications].Additional genetic risk factor for death in children with acute lymphoblastic leukemia: a common polymorphism of the MTHFR gene.Incidence, clinical outcome, and management of virus-induced hemorrhagic cystitis in children and adolescents after allogeneic hematopoietic cell transplantation.A three-way translocation of MLL, MLLT11, and the novel reciprocal partner gene MYO18A in a child with acute myeloid leukemia.Megachemotherapy followed by autologous stem cell transplantation in children with Ewing's sarcoma.Chronic metastatic neuroblastoma.Monitoring of hematopoietic chimerism after sex-mismatched allogeneic stem cell transplantation (alloSCT) by dual-color FISH analysis of X and Y chromosomes.[Assessment of lipid layer thickness of tear film in the diagnosis of dry-eye syndrome in children after the hematopoietic stem cell transplantation].[Prophylaxis of vitamin D deficiency--Polish recommendations 2009].Consolidation of first-line therapy with busulphan and melphalan, and autologous stem cell rescue in children with Ewing's sarcoma.Pax3-fkhr and pax7-fkhr fusion genes impact outcome of alveolar rhabdomyosarcoma in children.[Coexistence of Langerhans cell histiocytosis and Niemann-Pick disease in children: a case report].[Treatment outcome for myelodysplastic syndromes (MDS) obtained by the Polish Children's Leukemia/Lymphoma Study Group].
P50
Q33347177-3DCE976E-D835-4162-B40E-977F6A34F230Q33439801-CD2DD921-882C-4E00-8E5A-F3DA7228B00CQ33517966-D26D62E0-BDE6-4D59-AE7B-A0367A86BF58Q35466913-BB5D665B-B174-41B7-AA28-009032128511Q36369011-F9D56BF6-15A8-4F29-BA1A-091310887BD3Q36736376-5DDD0AFE-A620-4121-9887-31CF05FB3791Q37216480-72EDD1CB-C882-4643-B216-AAB6ED231751Q37315426-8250A81D-F18E-4E18-B893-676FA3DD612FQ38132356-FD502A76-30AA-4520-81D0-6819DF0B8950Q38196511-F969699F-B859-4C2C-AE1A-68AA6D971CC8Q42749275-E3AE1040-906F-4E64-A1C6-87A35D6CCD2FQ43446075-A85A713D-96B0-4456-8C93-67E92D00123EQ43682818-7A2BB416-60A4-496E-93E6-75FBF8DCE888Q43994629-7E677C60-CA11-435E-8C5C-9D9E312C58F4Q44076140-5C4D1B50-DCE8-482A-A091-2B643E745810Q44076167-A8568F5D-CCC5-49ED-9C79-643312A721FAQ44076169-9A188A7E-C787-4798-8F52-0D1C33AB5BE2Q44208467-67CE3D3C-4843-4C78-B6FD-54FE68BB2D2AQ44569146-EA123AD8-645C-459D-91A3-2D4604740F17Q44577227-6FC4A395-89BB-4499-946F-9C72E37042C8Q44629444-9D577D24-4C92-4698-BA1B-7989F499381CQ44699233-F08732D1-1849-415C-A758-9D8C59D20761Q45247502-9623692A-F82D-4EF0-A0F3-509725EBD73CQ45247504-CBF1F47D-8491-46AC-A714-6EB74D3B06ADQ45247508-E7C37460-126F-4121-BCDC-18877856BACFQ45249275-95989B1E-8719-4240-B7CA-CB94D6D356D2Q45323271-5F79B3A7-8B2F-44E6-A4F3-6E422ECA0890Q45423746-082CABB4-248A-4B96-B1ED-F9CBC92C9261Q46526983-A8FBA965-95EB-4AA2-A9D5-4416776BF5FBQ46714695-8C9CD489-9972-46ED-9218-0B00906954C9Q46968058-8A87D47A-A38C-4DE9-BAF5-A8DD2ADA5848Q47761362-7BBEE91C-CCF3-47F2-AB8B-3DA9DB1E29BFQ50512292-F5DFCD1A-58C5-4DA8-8D29-D392E0FAB860Q51911276-52936391-F71C-4C58-9EF8-0DD7BA0C1316Q53167841-38DD6223-586E-4728-A8BE-D5F3828CA885Q53331390-61C6DD79-68EB-4AA8-BE31-2C5675CC21FFQ64049651-6C759429-13C3-4D80-A00A-6EB854959127Q64930229-8F371BF5-8C73-4774-B754-C0BE22E811A3
P50
description
Polish oncologist
@en
Pools politica
@nl
dokter
@id
femme politique polonaise
@fr
oncóloga polaca
@es
politica polacca
@it
polnische Politikerin, Mitglied des Sejm
@de
polska lekarka, pediatra, onkolog
@pl
política polaca
@pt
name
Alicja Chybicka
@ast
Alicja Chybicka
@ca
Alicja Chybicka
@da
Alicja Chybicka
@de
Alicja Chybicka
@en
Alicja Chybicka
@es
Alicja Chybicka
@fi
Alicja Chybicka
@fr
Alicja Chybicka
@ga
Alicja Chybicka
@it
type
label
Alicja Chybicka
@ast
Alicja Chybicka
@ca
Alicja Chybicka
@da
Alicja Chybicka
@de
Alicja Chybicka
@en
Alicja Chybicka
@es
Alicja Chybicka
@fi
Alicja Chybicka
@fr
Alicja Chybicka
@ga
Alicja Chybicka
@it
altLabel
Alicja Paulina Chybicka
@pl
prefLabel
Alicja Chybicka
@ast
Alicja Chybicka
@ca
Alicja Chybicka
@da
Alicja Chybicka
@de
Alicja Chybicka
@en
Alicja Chybicka
@es
Alicja Chybicka
@fi
Alicja Chybicka
@fr
Alicja Chybicka
@ga
Alicja Chybicka
@it
P106
P214
P227
P244
P8172
P102
P1207
P1412
P1559
Alicja Chybicka
@pl
P19
P21
P213
0000 0000 3622 6395
P214
P227
1059787970
P244
n2004124618